Raffi Asadorian

2020 - AcelRx Pharmaceuticals

In 2020, Raffi Asadorian earned a total compensation of $890.7K as Chief Financial Officer at AcelRx Pharmaceuticals, a 12% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$150,055
Option Awards$168,111
Salary$442,900
Stock Awards$118,250
Other$11,400
Total$890,716

Asadorian received $442.9K in salary, accounting for 50% of the total pay in 2020.

Asadorian also received $150.1K in non-equity incentive plan, $168.1K in option awards, $118.3K in stock awards and $11.4K in other compensation.

Rankings

In 2020, Raffi Asadorian's compensation ranked 9,091st out of 13,090 executives tracked by ExecPay. In other words, Asadorian earned more than 30.6% of executives.

ClassificationRankingPercentile
All
9,091
out of 13,090
31st
Division
Manufacturing
3,884
out of 5,618
31st
Major group
Chemicals And Allied Products
1,572
out of 2,251
30th
Industry group
Drugs
1,375
out of 1,951
30th
Industry
Pharmaceutical Preparations
1,016
out of 1,456
30th
Source: SEC filing on June 3, 2022.

Asadorian's colleagues

We found two more compensation records of executives who worked with Raffi Asadorian at AcelRx Pharmaceuticals in 2020.

2020

Vincent Angotti

AcelRx Pharmaceuticals

Chief Executive Officer

2020

Pamela Palmer

AcelRx Pharmaceuticals

Chief Medical Officer

News

You may also like